Researchers monitored 377 HIV-positive babies for five years and found that those who completed the immediate 96-week antiretroviral treatment were able to avoid restarting the therapy for an average of 70 weeks. Waiting for symptoms to emerge before getting the treatment was linked to substantially higher rates of death and hospital admissions as well as greater medical costs than receiving the immediate, temporary treatment. The findings appear in The Lancet.

Full Story:
HealthDay News

Related Summaries